State Development and Reform Commission stipulates that the average price of 53 kinds of digestive drugs will be reduced by 17%

Yesterday, the National Development and Reform Commission issued a notice to adjust the maximum retail price limit for some drugs of the digestive system from May 1. The drug price adjustment involved a total of 53 varieties, more than 300 dosage form specifications, an average decline of 17%, of which high-priced drugs on average decreased by 22%, is expected to reduce the burden on the people each year more than 3 billion yuan.

The National Development and Reform Commission stated that it will further improve the pricing mechanism. First, it is necessary to strengthen the investigation and monitoring of costs and factory prices, and lay the foundation for a reasonable determination of the ceiling price level. At the same time, we will improve the pricing of medicines. We will use some drugs to evaluate the economic evaluation of drugs and the pricing of international prices. We will try to set a unified pricing model for some drugs. We must also increase the price cuts for high-priced drugs, focus on standardizing the price behavior of drug circulation, and establish a dynamic adjustment mechanism for drug prices.

In addition, we will also study and implement pricing policies that encourage innovation in drug research and development. For generic drugs that have reached international standards, support is provided for price policies.